| 靶点: |
K-Ras(G12C):<0.01 μM (IC50);Ras |
| 体外研究: |
Divarasib (compound 17a) has an EC50 of 2 nM in K-Ras G12C-alkylation HCC1171 cells. |
| 体内研究: |
Divarasib (10-100 mg/kg/day; PO for 7 days) decreases the ratio of free KRAS G12C. |
| 参考文献: |
1. Lingyao Meng, et al. Assessment of KRAS G12C Target Engagement by a Covalent Inhibitor in Tumor Biopsies Using an Ultra-Sensitive Immunoaffinity 2D-LC-MS/MS Approach. Anal Chem. 2022 Sep 20;94(37):12927-12933.
2. Sushant Malhotra, et al. Fused ring compounds. WO2020097537A2. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.608 ml |
8.038 ml |
16.076 ml |
| 5 mM |
0.322 ml |
1.608 ml |
3.215 ml |
| 10 mM |
0.161 ml |
0.804 ml |
1.608 ml |
| 50 mM |
0.032 ml |
0.161 ml |
0.322 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |